Details about Amanda Megan Cole

Access statistics for papers by Amanda Megan Cole.

Last updated 2022-02-10. Update your information in the RePEc Author Service.

Short-id: pco941

Working Papers

2019

1. Documento de debate sobre la fijación de precios en función de la indicación (IBP) ¿Deben variar los precios de los medicamentos según la indicación?
   Briefing, Office of Health Economics
2. Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
   Briefing, Office of Health Economics

2016

3. How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?
   Briefing, Office of Health Economics
4. “New Age” Decision Making in HTA: Is It Applicable in Asia?
   Briefing, Office of Health Economics

Journal Articles

2020

1. Outcome-Based Payment Schemes: What Outcomes Do Patients with Cancer Value?
   The Patient: Patient-Centered Outcomes Research, 2020, 13, (5), 599-610 View citations (1)

2018

2. Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment
   The European Journal of Health Economics, 2018, 19, (4), 595-605 View citations (3)

2017

3. A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?
   Applied Health Economics and Health Policy, 2017, 15, (4), 469-477 View citations (4)

2014

4. Are the UK Systems of Innovation and Evaluation of Medical Devices Compatible? The Role of NICE’s Medical Technologies Evaluation Programme (MTEP)
   Applied Health Economics and Health Policy, 2014, 12, (4), 347-357 View citations (3)